Protein Expression

Protein Expression

Global Protein Expression Market to Reach US$7.9 Billion by 2030

The global market for Protein Expression estimated at US$3.4 Billion in the year 2023, is expected to reach US$7.9 Billion by 2030, growing at a CAGR of 13.0% over the analysis period 2023-2030. Prokaryotic Expression Systems, one of the segments analyzed in the report, is expected to record a 13.7% CAGR and reach US$2.7 Billion by the end of the analysis period. Growth in the Mammalian Cell Expression Systems segment is estimated at 13.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$907.0 Million While China is Forecast to Grow at 12.0% CAGR

The Protein Expression market in the U.S. is estimated at US$907.0 Million in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.2 Billion by the year 2030 trailing a CAGR of 12.0% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 11.7% and 10.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 9.2% CAGR.

Global Protein Expression Market - Key Trends and Drivers Summarized

Unveiling the Mechanisms: The Growing Market for Protein Expression

Protein expression is a fundamental process in biotechnology and pharmaceutical research, enabling the production of specific proteins for various applications, including drug development, therapeutic production, and industrial enzyme manufacturing. The ability to express proteins in different systems, such as bacterial, yeast, insect, and mammalian cells, allows researchers to produce proteins with specific post-translational modifications and functional properties. This versatility is critical for the development of biologics, including monoclonal antibodies, vaccines, and recombinant proteins. As the demand for biologics continues to rise, the importance of efficient and scalable protein expression systems has become increasingly apparent, driving innovation in this field.

How Are Advancements in Expression Systems and Technologies Impacting the Market?

Advancements in protein expression systems and technologies have significantly enhanced the efficiency, scalability, and versatility of protein production. The development of new expression vectors and host cell lines has improved protein yield and quality, making it easier to produce complex proteins with the desired functional properties. Innovations in cell culture technologies, such as perfusion and fed-batch systems, have also increased the scalability of protein production, allowing for the efficient production of biologics on an industrial scale. Additionally, the use of synthetic biology and genetic engineering techniques has enabled the customization of expression systems to meet specific research and production needs. These technological advancements are driving the adoption of advanced protein expression systems in both academic research and commercial bioproduction.

What Are the Emerging Applications of Protein Expression?

Protein expression is increasingly being applied in emerging fields such as gene therapy, personalized medicine, and synthetic biology. In gene therapy, protein expression systems are used to produce therapeutic proteins that can replace or repair defective genes in patients with genetic disorders. The rise of personalized medicine has also driven the demand for customized protein expression systems that can produce patient-specific proteins for targeted therapies. In synthetic biology, protein expression is used to engineer microorganisms to produce biofuels, pharmaceuticals, and other valuable compounds. These emerging applications are expanding the scope of protein expression, making it a critical tool in modern biotechnology and pharmaceutical research.

What Are the Key Growth Drivers in the Market?

The growth in the protein expression market is driven by several factors. The increasing demand for biologics, including monoclonal antibodies, vaccines, and recombinant proteins, is a major driver, as efficient protein expression systems are essential for their production. Technological advancements in expression systems and cell culture technologies have significantly improved the efficiency and scalability of protein production, driving their adoption in research and industrial settings. The rise of personalized medicine and gene therapy has also spurred the demand for customized protein expression systems that can produce patient-specific proteins. Additionally, the growing focus on synthetic biology and the development of novel bioproduction methods are further propelling the market.

Select Competitors (Total 46 Featured) -

• Batavia Biosciences BV
• Beijing CC-Pharming Ltd.
• BioChain Institute, Inc.
• Biognosys
• Canopy Biosciences, LLC
• Cube Biotech GmbH
• Elabscience Biotechnology Inc.
• ExcellGene
• GenScript Biotech Corporation
• Green Mountain Antibodies

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.